Je was op zoek naar: coronary arteries (Deens - Italiaans)

clinical investigation of medicinal products for the treatment of unstable coronary artery disease
clinical investigation of medicinal products for the treatment of unstable coronary artery disease

bearbejdet efter "prevention of coronary heart disease in clinical practice:
17 warfarina la contemporanea somministrazione di {nome di fantasia} e warfarina ha dato luogo ad una piccola diminuzione del tempo di protrombina durante i primi giorni di terapia che si è normalizzato entro 15 giorni di trattamento con {nome di fantasia}.

denne indikation er baseret på resultaterne af én undersøgelse, woscops (the west of scotland coronary prevention study).
questa indicazione si basa sui risultati di uno studio sugli esiti della terapia, il woscops (west of scotland coronary prevention study).

points to consider on the clinical investigation of new medicinal products for treatment of acute coronary syndrome (acs) without persistent st- segment elevation
treatment of acute coronary syndrome (acs) without persistent st-segment elevation concept paper on the development of a cpmp note for guidance on the clinical

recommendations of the second joint task force of european and other societies on coronary prevention "publiceret i atherosclerosis 140 (1998) 199- 270.
recommendations of the second joint task force of european and other societies on coronary prevention” in atherosclerosis 140 (1998) 199-270.

24, 47%; p < 0. 001), der hovedsagligt var relateret til en reduktion af infarkt - relaterede okkluderede arterier.
24, 47%; p < 0,001), principalmente correlata ad una riduzione delle occlusioni delle arterie correlate all’ infarto.